ALK and lung cancer: In addition, a study using DNA-based NGS analysis of ctDNA samples from patients with lung cancer showed a sensitivity of only 54.2% for detection of ALK fusions, suggesting that oncogenic fusion detection may be challenging in ctDNA samples44.